Angiopoietin 1: Difference between revisions
CSV import |
CSV import |
||
| Line 26: | Line 26: | ||
{{Protein-stub}} | {{Protein-stub}} | ||
{{Gene-stub}} | {{Gene-stub}} | ||
{{No image}} | |||
Revision as of 06:19, 10 February 2025
Angiopoietin 1 (also known as ANG-1) is a type of protein that in humans is encoded by the ANGPT1 gene. It is a vital component of the angiopoietin-Tie2 signaling pathway, which is critical for the development and maturation of blood vessels.
Function
ANG-1 is a secreted glycoprotein that plays a crucial role in the formation of blood vessels. It binds with the receptor tyrosine kinase Tie2, activating a signaling pathway that promotes angiogenesis, the process by which new blood vessels form from pre-existing ones. This interaction is essential for the stability and maturation of the vascular network.
Clinical Significance
Alterations in the ANG-1/Tie2 pathway have been associated with various pathological conditions. For instance, reduced levels of ANG-1 and increased levels of its antagonist, angiopoietin 2 (ANG-2), have been observed in patients with sepsis and acute lung injury. Moreover, ANG-1 has been implicated in the pathogenesis of cancer, as it can promote tumor angiogenesis and growth.
Research
Research into the role of ANG-1 in health and disease is ongoing. Studies are investigating its potential as a therapeutic target in conditions such as cancer, cardiovascular disease, and sepsis. For example, drugs that mimic the action of ANG-1 or enhance its activity could potentially be used to stimulate angiogenesis in patients with cardiovascular disease or to inhibit tumor growth in cancer patients.
See Also

